X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (74) 74
humans (64) 64
ophthalmology (62) 62
male (38) 38
female (36) 36
adult (22) 22
middle aged (21) 21
aged (20) 20
animals (17) 17
medicine & public health (16) 16
congenital toxoplasmosis (15) 15
retinochoroiditis (15) 15
treatment outcome (15) 15
visual acuity (14) 14
ocular toxoplasmosis (12) 12
surgery (12) 12
aged, 80 and over (11) 11
follow-up studies (11) 11
intravitreal injections (11) 11
retrospective studies (11) 11
adolescent (10) 10
analysis (10) 10
follow-up (10) 10
cytokines (9) 9
ranibizumab (9) 9
toxoplasmosis, ocular - immunology (9) 9
uveitis (9) 9
chemokines (8) 8
child (8) 8
children (8) 8
disease (8) 8
inflammation (8) 8
toxoplasma - immunology (8) 8
diagnosis (7) 7
eye (7) 7
eye diseases (7) 7
immunology (7) 7
infection (7) 7
medicine (7) 7
prognosis (7) 7
prospective studies (7) 7
rabbits (7) 7
recurrence (7) 7
risk factors (7) 7
toxoplasma gondii (7) 7
vitrectomy (7) 7
abridged index medicus (6) 6
acquired toxoplasmosis (6) 6
age (6) 6
antibodies, protozoan - blood (6) 6
biomarkers (6) 6
care and treatment (6) 6
chorioretinitis - parasitology (6) 6
corticosteroids (6) 6
degeneration (6) 6
macular degeneration (6) 6
macular edema - drug therapy (6) 6
management (6) 6
microbiology (6) 6
parasitology (6) 6
pediatrics (6) 6
pharmacology & pharmacy (6) 6
polymerase-chain-reaction (6) 6
pregnancy (6) 6
research (6) 6
retinal detachment (6) 6
time factors (6) 6
tomography, optical coherence (6) 6
toxoplasmosis (6) 6
toxoplasmosis, ocular - diagnosis (6) 6
visual acuity - physiology (6) 6
aids (5) 5
aqueous humor (5) 5
aqueous humor - immunology (5) 5
elisa (5) 5
glaucoma (5) 5
gondii (5) 5
gondii infection (5) 5
health aspects (5) 5
infectious diseases (5) 5
pars-plana vitrectomy (5) 5
pcr (5) 5
proliferative vitreoretinopathy (5) 5
retina (5) 5
toxoplasmosis, ocular - drug therapy (5) 5
vascular endothelial growth factor (5) 5
übersicht (5) 5
angiogenesis inhibitors - therapeutic use (4) 4
antibodies, protozoan - analysis (4) 4
antigens (4) 4
antiprotozoal agents - therapeutic use (4) 4
bevacizumab (4) 4
cell count (4) 4
child, preschool (4) 4
chorioretinitis (4) 4
chorioretinitis - diagnosis (4) 4
chronic disease (4) 4
cohort studies (4) 4
dexamethasone (4) 4
diabetic retinopathy - drug therapy (4) 4
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Der Ophthalmologe, ISSN 0941-293X, 02/2019
Journal Article
Clinical ophthalmology (Auckland, N.Z.), ISSN 1177-5467, 2019, Volume 13, pp. 1289 - 1295
To review published evidence for a treatment interval extension to ≥12-weeks in neovascular macular degeneration treated with intravitreal Aflibercept. A... 
Macular degeneration | Studies | Clinical trials | Systematic review | Clinical medicine | Ophthalmology | Vascular endothelial growth factor | Drug dosages | Age | neovascular age-related macular degeneration | intravitreal anti-VEGF injections | proactive treatment | review | AMD | long-term outcome | treat-and-extend | Aflibercept
Journal Article
Klinische Monatsblatter fur Augenheilkunde, ISSN 0023-2165, 04/2018, Volume 235, Issue 4, pp. 373 - 376
Background Pediatric uveitis is associated with a high incidence of severe and frequently permanent visual loss. This article summarizes the current... 
pediatric uveitis | macular edema | vision loss | intraocular inflammations | complications | pediatric ophthalmology | EFFICACY | DEXAMETHASONE INTRAVITREAL IMPLANT | JUVENILE IDIOPATHIC ARTHRITIS | REFERRAL CENTER | CHILDREN | OPHTHALMOLOGY | QUALITY-OF-LIFE | OUTCOMES | INTERMEDIATE UVEITIS
Journal Article
06/2009
Although parasite-mediated host cell lysis is deemed to be an important cause of tissue destruction in ocular toxoplasmosis (OT), the severity of the disease... 
ocular toxoplasmosis - acquired toxoplasmosis - congenitally contracted toxoplasmosis - experimental autoimmune uveitis - cytokines - chemokines
Web Resource
Retina (Philadelphia, Pa.), ISSN 0275-004X, 05/2019, Volume 39, Issue 5, pp. 853 - 859
To assess the impact of inner limiting membrane peeling during vitrectomy for macula-involving retinal detachment on best-corrected visual acuity (VA).... 
visual recovery | inner limiting membrane | vitrectomy | macular involvement | SYMPTOM DURATION | SCLERAL BUCKLING SURGERY | REPAIR | REMOVAL | rhegmatogenous retinal detachment | PARS-PLANA VITRECTOMY | EPIMACULAR MEMBRANE | EPIRETINAL MEMBRANE | OPHTHALMOLOGY | MACULAR HOLE | OUTCOMES | THICKNESS | Retinal detachment | Vitrectomy | Care and treatment | Patient outcomes
Journal Article
Graefe's Archive for Clinical and Experimental Ophthalmology, ISSN 0721-832X, 12/2016, Volume 254, Issue 12, pp. 2479 - 2480
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1007/s00417-016-3459-y 
Medicine & Public Health | Ophthalmology | OPHTHALMOLOGY | MACULAR EDEMA SECONDARY | Dexamethasone | Glucocorticoids | Intravitreal Injections | Humans | Drug Implants | Macular Edema | Retinal Vein Occlusion | Visual Acuity | Usage | Steroids | Index Medicus
Journal Article
Graefe's Archive for Clinical and Experimental Ophthalmology, ISSN 0721-832X, 09/2017, Volume 255, Issue 9, p. 1763
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1007/s00417-017-3724-8... 
Development and progression | Bone morphogenetic proteins | Cataract | Transforming growth factors | Analysis | Surgery | Glaucoma | Ophthalmology | Isoforms
Journal Article
Klinische Monatsblatter fur Augenheilkunde, 04/2019, Volume 236, Issue 4, p. 487
Acute posterior and panuveitis mostly affect younger patients and affect both eyes in more than half of cases. Because of the severe consequences in the... 
Journal Article
DIABETES CARE, ISSN 0149-5992, 11/2010, Volume 33, Issue 11, pp. 2399 - 2405
OBJECTIVE- The expression of vascular endothelial growth factor (VEGF) is elevated in diabetic macular edema (DME). Ranibizumab binds to and inhibits multiple... 
LASER | ENDOCRINOLOGY & METABOLISM | PHOTOCOAGULATION | RANDOMIZED-TRIAL | RETINOPATHY | INTRAVITREAL BEVACIZUMAB | TRIAMCINOLONE | PROGRESSION | DEGENERATION
Journal Article
Expert Review of Ophthalmology, ISSN 1746-9899, 02/2013, Volume 8, Issue 1, pp. 33 - 35
Journal Article
Journal Article
Acta Ophthalmologica, ISSN 1755-375X, 06/2019, Volume 97, Issue 4, pp. e580 - e588
Journal Article
Graefe's Archive for Clinical and Experimental Ophthalmology, ISSN 0721-832X, 8/2018, Volume 256, Issue 8, pp. 1553 - 1555
To access, purchase, authenticate, or subscribe to the full-text of this article, please visit this link: http://dx.doi.org/10.1007/s00417-018-4005-x 
Medicine & Public Health | Ophthalmology | NEOVASCULAR AMD | TRIAL | MANAGEMENT | EFFICACY | OPHTHALMOLOGY | REGIMEN | RANIBIZUMAB | Macular degeneration | Physiological aspects | Prognosis | Endothelial growth factors | Degeneration | Vascular endothelial growth factor | Age
Journal Article
Ocular immunology and inflammation, 08/2013, Volume 21, Issue 4, p. 300
Treatment of ocular toxoplasmosis is aimed at stabilizing visual function and reducing recurrence rates. Small controlled studies indicate that available... 
Animals | Humans | Antibiotic Prophylaxis - methods | Toxoplasma - isolation & purification | Toxoplasmosis, Ocular - drug therapy | Antiprotozoal Agents - therapeutic use | Visual Acuity
Journal Article
No results were found for your search.

Cannot display more than 1000 results, please narrow the terms of your search.